Overall Technical outlook

Price Summary

On 2025-09-05, JUBLPHARMA's stock started at 1064.8, reached a high of 1073.7, fell to 1051.7, and ended 0.53% up at 1070.4, with 105084 shares traded.
The highest price the stock achieved in the past 52 weeks is 1254.55, while the lowest price it saw is 828.1.

Technicals

Support and Resistance: At 1070.4, the price is supported at 1053.7 and faces resistance at 1094.2. This range suggests that the price for JUBLPHARMA might stay between these levels, with 1053.7 acting as a floor and 1094.2 as a ceiling.
JUBLPHARMA supportResistance 5b173e
Support/Resistance for JUBLPHARMA


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
JUBLPHARMA aroon 5b173e
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
JUBLPHARMA bbands 5b173e
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR continues to be bullish for JUBLPHARMA, setting a strong support level that could sustain the ongoing upward trend. This level of support indicates that the market is likely to continue its positive trajectory, offering a base for continued bullish movement.
JUBLPHARMA psar 5b173e
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The STOCHASTIC is in a neutral stance for JUBLPHARMA, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
JUBLPHARMA stoch 5b173e
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
JUBLPHARMA trippleSMA 5b173e
Tripple SMA chart for Jubilant Pharmova Limited


To properly assess the technical data of a company, it's important to first look at its fundamentals, such as its earnings, growth potential, and management effectiveness. Equally, understanding the industry trends, competition, and external economic factors that influence the company is vital. This holistic view helps draw meaningful conclusions about the company's technical performance, allowing investors to better gauge its stock price behavior, volatility, and market trends.